U.S. Markets close in 5 hrs 38 mins

China Bio Cassava Holdings Limited (8129.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
0.101+0.00 (+1.00%)
At close: 3:59PM HKT

China Bio Cassava Holdings Limited

Unit 3912
Hong Kong
852 3104 8095

IndustryTechnical & System Software
Full Time Employees28

Key Executives

Mr. Yu Keung PoonCompliance Officer and Exec. Director518kN/A52
Mr. Ching Fung HungExec. Director498kN/A33
Mr. Lap Chin TangExec. DirectorN/AN/A64
Mr. Chung Yuen NgExec. DirectorN/AN/A64
Ms. Man Kwan NgCompany Sec.N/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.


China Bio Cassava Holdings Limited, an investment holding company, develops, sells, and licenses computer software and embedded systems in Hong Kong. The company’s products and services comprise Matrix mapping system, Q9 CIS, and Qcode Chinese character inputting system. It also researches and develops biotech renewable energy; and provides institution and corporate, and financing services. The company was formerly known as Bio Cassava Technology Holdings Limited and changed its name to China Bio Cassava Holdings Limited in June 2008. China Bio Cassava Holdings Limited was founded in 1995 and is based in Central, Hong Kong.

Corporate Governance

China Bio Cassava Holdings Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.